Cargando…
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study (NCT03226886) integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118 were SARS-CoV-2-positive, 94 were symptomatic and 2 patients died of COV...
Ejemplares similares
-
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
por: Fendler, Annika, et al.
Publicado: (2021) -
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer
por: Angelis, Vasileios, et al.
Publicado: (2020) -
How we treat neurological toxicity from immune checkpoint inhibitors
por: Spain, Lavinia, et al.
Publicado: (2019) -
Primary pyogenic ventriculitis caused by Neisseria meningitidis: case report and review of the literature
por: Gronthoud, Firza, et al.
Publicado: (2017) -
COVID-19 cancer conundrum—evidence driving decisions or the lack of it?
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)